Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 325

1.

DeepHarmony: A deep learning approach to contrast harmonization across scanner changes.

Dewey BE, Zhao C, Reinhold JC, Carass A, Fitzgerald KC, Sotirchos ES, Saidha S, Oh J, Pham DL, Calabresi PA, van Zijl PCM, Prince JL.

Magn Reson Imaging. 2019 Jul 10. pii: S0730-725X(18)30649-0. doi: 10.1016/j.mri.2019.05.041. [Epub ahead of print]

PMID:
31301354
2.

Early complement genes are associated with visual system degeneration in multiple sclerosis.

Fitzgerald KC, Kim K, Smith MD, Aston SA, Fioravante N, Rothman AM, Krieger S, Cofield SS, Kimbrough DJ, Bhargava P, Saidha S, Whartenby KA, Green AJ, Mowry EM, Cutter GR, Lublin FD, Baranzini SE, De Jager PL, Calabresi PA.

Brain. 2019 Jul 9. pii: awz188. doi: 10.1093/brain/awz188. [Epub ahead of print]

PMID:
31289819
3.

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.

Cadavid D, Mellion M, Hupperts R, Edwards KR, Calabresi PA, Drulović J, Giovannoni G, Hartung HP, Arnold DL, Fisher E, Rudick R, Mi S, Chai Y, Li J, Zhang Y, Cheng W, Xu L, Zhu B, Green SM, Chang I, Deykin A, Sheikh SI; SYNERGY study investigators.

Lancet Neurol. 2019 Jul 5. pii: S1474-4422(19)30137-1. doi: 10.1016/S1474-4422(19)30137-1. [Epub ahead of print]

PMID:
31285147
4.

Applications of a deep learning method for anti-aliasing and super-resolution in MRI.

Zhao C, Shao M, Carass A, Li H, Dewey BE, Ellingsen LM, Woo J, Guttman MA, Blitz AM, Stone M, Calabresi PA, Halperin H, Prince JL.

Magn Reson Imaging. 2019 Jun 24. pii: S0730-725X(18)30650-7. doi: 10.1016/j.mri.2019.05.038. [Epub ahead of print]

PMID:
31247254
5.

Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures.

Murphy OC, Kwakyi O, Iftikhar M, Zafar S, Lambe J, Pellegrini N, Sotirchos ES, Gonzalez-Caldito N, Ogbuokiri E, Filippatou A, Risher H, Cowley N, Feldman S, Fioravante N, Frohman EM, Frohman TC, Balcer LJ, Prince JL, Channa R, Calabresi PA, Saidha S.

Mult Scler. 2019 May 16:1352458519845116. doi: 10.1177/1352458519845116. [Epub ahead of print]

PMID:
31094280
6.

Longitudinal assessment of hand function in individuals with multiple sclerosis.

Newsome SD, von Geldern G, Shou H, Baynes M, Marasigan RER, Calabresi PA, Zackowski KM.

Mult Scler Relat Disord. 2019 Jul;32:107-113. doi: 10.1016/j.msard.2019.04.035. Epub 2019 May 6.

PMID:
31085489
7.

Macular Ganglion Cell and Inner Plexiform Layer Thickness Is More Strongly Associated With Visual Function in Multiple Sclerosis Than Bruch Membrane Opening-Minimum Rim Width or Peripapillary Retinal Nerve Fiber Layer Thicknesses.

Nguyen J, Rothman A, Gonzalez N, Avornu A, Ogbuokiri E, Balcer LJ, Galetta SL, Frohman EM, Frohman T, Crainiceanu C, Calabresi PA, Saidha S.

J Neuroophthalmol. 2019 Mar 26. doi: 10.1097/WNO.0000000000000768. [Epub ahead of print]

PMID:
30921169
8.

Quantitative vibratory sensation measurement is related to sensory cortical thickness in MS.

Fritz NE, Eloyan A, Glaister J, Dewey BE, Al-Louzi O, Costello MG, Chen M, Prince JL, Calabresi PA, Zackowski KM.

Ann Clin Transl Neurol. 2019 Feb 19;6(3):586-595. doi: 10.1002/acn3.734. eCollection 2019 Mar.

9.

Layer boundary evolution method for macular OCT layer segmentation.

Liu Y, Carass A, He Y, Antony BJ, Filippatou A, Saidha S, Solomon SD, Calabresi PA, Prince JL.

Biomed Opt Express. 2019 Feb 4;10(3):1064-1080. doi: 10.1364/BOE.10.001064. eCollection 2019 Mar 1.

10.

Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study.

Nolan-Kenney RC, Liu M, Akhand O, Calabresi PA, Paul F, Petzold A, Balk L, Brandt AU, Martínez-Lapiscina EH, Saidha S, Villoslada P, Al-Hassan AA, Behbehani R, Frohman EM, Frohman T, Havla J, Hemmer B, Jiang H, Knier B, Korn T, Leocani L, Papadopoulou A, Pisa M, Zimmermann H, Galetta SL, Balcer LJ; International Multiple Sclerosis Visual System Consortium.

Ann Neurol. 2019 May;85(5):618-629. doi: 10.1002/ana.25462. Epub 2019 Apr 10.

PMID:
30851125
11.

Retinal measurements predict 10-year disability in multiple sclerosis.

Rothman A, Murphy OC, Fitzgerald KC, Button J, Gordon-Lipkin E, Ratchford JN, Newsome SD, Mowry EM, Sotirchos ES, Syc-Mazurek SB, Nguyen J, Caldito NG, Balcer LJ, Frohman EM, Frohman TC, Reich DS, Crainiceanu C, Saidha S, Calabresi PA.

Ann Clin Transl Neurol. 2019 Jan 19;6(2):222-232. doi: 10.1002/acn3.674. eCollection 2019 Feb.

12.

Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.

Oh J, Ontaneda D, Azevedo C, Klawiter EC, Absinta M, Arnold DL, Bakshi R, Calabresi PA, Crainiceanu C, Dewey B, Freeman L, Gauthier S, Henry R, Inglese M, Kolind S, Li DKB, Mainero C, Menon RS, Nair G, Narayanan S, Nelson F, Pelletier D, Rauscher A, Rooney W, Sati P, Schwartz D, Shinohara RT, Tagge I, Traboulsee A, Wang Y, Yoo Y, Yousry T, Zhang Y, Sicotte NL, Reich DS; North American Imaging in Multiple Sclerosis Cooperative.

Neurology. 2019 Mar 12;92(11):519-533. doi: 10.1212/WNL.0000000000007099. Epub 2019 Feb 20. Review. Erratum in: Neurology. 2019 Jul 2;93(1):46.

PMID:
30787160
13.

Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement.

Bhargava P, Wicken C, Smith MD, Strowd RE, Cortese I, Reich DS, Calabresi PA, Mowry EM.

Mult Scler Relat Disord. 2019 May;30:136-140. doi: 10.1016/j.msard.2019.02.013. Epub 2019 Feb 11.

PMID:
30771580
14.

Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.

Sotirchos ES, Gonzalez-Caldito N, Dewey BE, Fitzgerald KC, Glaister J, Filippatou A, Ogbuokiri E, Feldman S, Kwakyi O, Risher H, Crainiceanu C, Pham DL, Van Zijl PC, Mowry EM, Reich DS, Prince JL, Calabresi PA, Saidha S.

Mult Scler. 2019 Feb 11:1352458519826364. doi: 10.1177/1352458519826364. [Epub ahead of print]

PMID:
30741108
15.

Retinal layer parcellation of optical coherence tomography images: Data resource for multiple sclerosis and healthy controls.

He Y, Carass A, Solomon SD, Saidha S, Calabresi PA, Prince JL.

Data Brief. 2018 Dec 28;22:601-604. doi: 10.1016/j.dib.2018.12.073. eCollection 2019 Feb.

16.

Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes.

Bhargava P, Fitzgerald KC, Venkata SLV, Smith MD, Kornberg MD, Mowry EM, Haughey NJ, Calabresi PA.

Ann Clin Transl Neurol. 2018 Oct 30;6(1):33-45. doi: 10.1002/acn3.676. eCollection 2019 Jan.

17.

Multisite reliability and repeatability of an advanced brain MRI protocol.

Schwartz DL, Tagge I, Powers K, Ahn S, Bakshi R, Calabresi PA, Todd Constable R, Grinstead J, Henry RG, Nair G, Papinutto N, Pelletier D, Shinohara R, Oh J, Reich DS, Sicotte NL, Rooney WD; NAIMS Cooperative.

J Magn Reson Imaging. 2019 Jan 16. doi: 10.1002/jmri.26652. [Epub ahead of print]

PMID:
30652391
18.

PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R).

Horti AG, Naik R, Foss CA, Minn I, Misheneva V, Du Y, Wang Y, Mathews WB, Wu Y, Hall A, LaCourse C, Ahn HH, Nam H, Lesniak WG, Valentine H, Pletnikova O, Troncoso JC, Smith MD, Calabresi PA, Savonenko AV, Dannals RF, Pletnikov MV, Pomper MG.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1686-1691. doi: 10.1073/pnas.1812155116. Epub 2019 Jan 11.

PMID:
30635412
19.

Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness.

Filippatou A, Shoemaker T, Esch M, Qutab M, Gonzalez-Caldito N, Prince JL, Mowry EM, Calabresi PA, Saidha S, Sotirchos ES.

Mult Scler. 2018 Dec 3:1352458518815597. doi: 10.1177/1352458518815597. [Epub ahead of print]

PMID:
30507269
20.

Alu insertion variants alter mRNA splicing.

Payer LM, Steranka JP, Ardeljan D, Walker J, Fitzgerald KC, Calabresi PA, Cooper TA, Burns KH.

Nucleic Acids Res. 2019 Jan 10;47(1):421-431. doi: 10.1093/nar/gky1086.

21.

The International Multiple Sclerosis Visual System Consortium: Advancing Visual System Research in Multiple Sclerosis.

Balcer LJ, Balk LJ, Brandt AU, Calabresi PA, Martinez-Lapiscina EH, Nolan RC, Paul F, Petzold A, Saidha S.

J Neuroophthalmol. 2018 Dec;38(4):494-501. doi: 10.1097/WNO.0000000000000732.

PMID:
30418332
22.

Microvascular blood flow velocities measured with a retinal function imager: inter-eye correlations in healthy controls and an exploration in multiple sclerosis.

Wang L, Kwakyi O, Nguyen J, Ogbuokiri E, Murphy O, Caldito NG, Balcer L, Frohman E, Frohman T, Calabresi PA, Saidha S.

Eye Vis (Lond). 2018 Nov 2;5:29. doi: 10.1186/s40662-018-0123-0. eCollection 2018.

23.

Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior.

Linville RM, DeStefano JG, Sklar MB, Xu Z, Farrell AM, Bogorad MI, Chu C, Walczak P, Cheng L, Mahairaki V, Whartenby KA, Calabresi PA, Searson PC.

Biomaterials. 2019 Jan;190-191:24-37. doi: 10.1016/j.biomaterials.2018.10.023. Epub 2018 Oct 25.

PMID:
30391800
24.

Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Caldito NG, Saidha S, Sotirchos ES, Dewey BE, Cowley NJ, Glaister J, Fitzgerald KC, Al-Louzi O, Nguyen J, Rothman A, Ogbuokiri E, Fioravante N, Feldman S, Kwakyi O, Risher H, Kimbrough D, Frohman TC, Frohman E, Balcer L, Crainiceanu C, Van Zijl PCM, Mowry EM, Reich DS, Oh J, Pham DL, Prince J, Calabresi PA.

Brain. 2018 Nov 1;141(11):3115-3129. doi: 10.1093/brain/awy245.

PMID:
30312381
25.

Emerging Applications of Optical Coherence Tomography Angiography (OCTA) in neurological research.

Wang L, Murphy O, Caldito NG, Calabresi PA, Saidha S.

Eye Vis (Lond). 2018 May 12;5:11. doi: 10.1186/s40662-018-0104-3. eCollection 2018. Review.

26.

Dice Overlap Measures for Objects of Unknown Number: Application to Lesion Segmentation.

Oguz I, Carass A, Pham DL, Roy S, Subbana N, Calabresi PA, Yushkevich PA, Shinohara RT, Prince JL.

Brainlesion. 2018;10670:3-14. doi: 10.1007/978-3-319-75238-9_1. Epub 2018 Feb 17.

27.

Joint Intensity Fusion Image Synthesis Applied to Multiple Sclerosis Lesion Segmentation.

Fleishman GM, Valcarcel A, Pham DL, Roy S, Calabresi PA, Yushkevich P, Shinohara RT, Oguz I.

Brainlesion. 2018;10670:43-54. Epub 2018 Feb 17.

28.

Visual Pathway Measures are Associated with Neuropsychological Function in Multiple Sclerosis.

Nguyen J, Rothman A, Fitzgerald K, Whetstone A, Syc-Mazurek S, Aquino J, Balcer LJ, Frohman EM, Frohman TC, Crainiceanu C, Beier M, Newsome SD, Calabresi PA, Saidha S.

Curr Eye Res. 2018 Jul;43(7):941-948. doi: 10.1080/02713683.2018.1459730. Epub 2018 May 1.

29.

Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.

Kornberg MD, Bhargava P, Kim PM, Putluri V, Snowman AM, Putluri N, Calabresi PA, Snyder SH.

Science. 2018 Apr 27;360(6387):449-453. doi: 10.1126/science.aan4665. Epub 2018 Mar 29.

30.

MIMoSA: An Automated Method for Intermodal Segmentation Analysis of Multiple Sclerosis Brain Lesions.

Valcarcel AM, Linn KA, Vandekar SN, Satterthwaite TD, Muschelli J, Calabresi PA, Pham DL, Martin ML, Shinohara RT.

J Neuroimaging. 2018 Jul;28(4):389-398. doi: 10.1111/jon.12506. Epub 2018 Mar 8.

31.

Central vein sign in multiple sclerosis: Ready for front and center?

Miller AE, Calabresi PA.

Neurology. 2018 Apr 3;90(14):631-632. doi: 10.1212/WNL.0000000000005241. Epub 2018 Mar 7. No abstract available.

PMID:
29514945
32.

An Automated Statistical Technique for Counting Distinct Multiple Sclerosis Lesions.

Dworkin JD, Linn KA, Oguz I, Fleishman GM, Bakshi R, Nair G, Calabresi PA, Henry RG, Oh J, Papinutto N, Pelletier D, Rooney W, Stern W, Sicotte NL, Reich DS, Shinohara RT; North American Imaging in Multiple Sclerosis Cooperative.

AJNR Am J Neuroradiol. 2018 Apr;39(4):626-633. doi: 10.3174/ajnr.A5556. Epub 2018 Feb 22.

33.

Bryostatin-1 alleviates experimental multiple sclerosis.

Kornberg MD, Smith MD, Shirazi HA, Calabresi PA, Snyder SH, Kim PM.

Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2186-2191. doi: 10.1073/pnas.1719902115. Epub 2018 Feb 12.

34.

Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis.

Nolan RC, Galetta SL, Frohman TC, Frohman EM, Calabresi PA, Castrillo-Viguera C, Cadavid D, Balcer LJ.

J Neuroophthalmol. 2018 Dec;38(4):451-458. doi: 10.1097/WNO.0000000000000629.

PMID:
29384802
35.

Defining response profiles after alemtuzumab: Rare paradoxical disease exacerbation.

Wiendl H, Calabresi PA, Meuth SG.

Neurology. 2018 Feb 13;90(7):309-311. doi: 10.1212/WNL.0000000000004969. Epub 2018 Jan 19. No abstract available.

PMID:
29352097
36.

Multiple Sclerosis.

Reich DS, Lucchinetti CF, Calabresi PA.

N Engl J Med. 2018 Jan 11;378(2):169-180. doi: 10.1056/NEJMra1401483. Review. No abstract available.

PMID:
29320652
37.

Advances in multiple sclerosis: from reduced relapses to remedies.

Calabresi PA.

Lancet Neurol. 2018 Jan;17(1):10-12. doi: 10.1016/S1474-4422(17)30417-9. Epub 2017 Dec 16. No abstract available.

PMID:
29262991
38.

Analysis of Agreement of Retinal-Layer Thickness Measures Derived from the Segmentation of Horizontal and Vertical Spectralis OCT Macular Scans.

Gonzalez Caldito N, Antony B, He Y, Lang A, Nguyen J, Rothman A, Ogbuokiri E, Avornu A, Balcer L, Frohman E, Frohman TC, Bhargava P, Prince J, Calabresi PA, Saidha S.

Curr Eye Res. 2018 Mar;43(3):415-423. doi: 10.1080/02713683.2017.1406526. Epub 2017 Dec 14.

39.

Distinguishing among multiple sclerosis fallers, near-fallers and non-fallers.

Fritz NE, Eloyan A, Baynes M, Newsome SD, Calabresi PA, Zackowski KM.

Mult Scler Relat Disord. 2018 Jan;19:99-104. doi: 10.1016/j.msard.2017.11.019. Epub 2017 Nov 22.

40.

Characteristics of morphologic macular abnormalities in neuroimmunology practice.

Al-Louzi O, Sotirchos ES, Vidal-Jordana A, Beh SC, Button J, Ying HS, Balcer LJ, Frohman EM, Saidha S, Calabresi PA, Newsome SD.

Mult Scler. 2019 Mar;25(3):361-371. doi: 10.1177/1352458517741206. Epub 2017 Nov 10.

PMID:
29125422
41.

Dimethyl fumarate treatment alters NK cell function in multiple sclerosis.

Smith MD, Calabresi PA, Bhargava P.

Eur J Immunol. 2018 Feb;48(2):380-383. doi: 10.1002/eji.201747277. Epub 2017 Dec 15.

42.

The NAIMS cooperative pilot project: Design, implementation and future directions.

Oh J, Bakshi R, Calabresi PA, Crainiceanu C, Henry RG, Nair G, Papinutto N, Constable RT, Reich DS, Pelletier D, Rooney W, Schwartz D, Tagge I, Shinohara RT, Simon JH, Sicotte NL; NAIMS Cooperative Steering Committee.

Mult Scler. 2018 Nov;24(13):1770-1772. doi: 10.1177/1352458517739990. Epub 2017 Nov 6.

PMID:
29106329
43.

Intensity inhomogeneity correction of SD-OCT data using macular flatspace.

Lang A, Carass A, Jedynak BM, Solomon SD, Calabresi PA, Prince JL.

Med Image Anal. 2018 Jan;43:85-97. doi: 10.1016/j.media.2017.09.008. Epub 2017 Oct 12.

44.

Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.

Bhargava P, Fitzgerald KC, Calabresi PA, Mowry EM.

JCI Insight. 2017 Oct 5;2(19). pii: 95302. doi: 10.1172/jci.insight.95302.

45.

Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination.

Baxi EG, DeBruin J, Jin J, Strasburger HJ, Smith MD, Orthmann-Murphy JL, Schott JT, Fairchild AN, Bergles DE, Calabresi PA.

Glia. 2017 Dec;65(12):2087-2098. doi: 10.1002/glia.23229. Epub 2017 Sep 22.

46.

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.

Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, Martinez-Lapiscina EH, Green AJ, Kardon R, Outteryck O, Paul F, Schippling S, Vermersch P, Villoslada P, Balk LJ; ERN-EYE IMSVISUAL.

Lancet Neurol. 2017 Oct;16(10):797-812. doi: 10.1016/S1474-4422(17)30278-8. Epub 2017 Sep 12. Review.

PMID:
28920886
47.

Thalamus segmentation using multi-modal feature classification: Validation and pilot study of an age-matched cohort.

Glaister J, Carass A, NessAiver T, Stough JV, Saidha S, Calabresi PA, Prince JL.

Neuroimage. 2017 Sep;158:430-440. doi: 10.1016/j.neuroimage.2017.06.047. Epub 2017 Jun 29.

48.

Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis.

Shinohara RT, Oh J, Nair G, Calabresi PA, Davatzikos C, Doshi J, Henry RG, Kim G, Linn KA, Papinutto N, Pelletier D, Pham DL, Reich DS, Rooney W, Roy S, Stern W, Tummala S, Yousuf F, Zhu A, Sicotte NL, Bakshi R; NAIMS Cooperative.

AJNR Am J Neuroradiol. 2017 Aug;38(8):1501-1509. doi: 10.3174/ajnr.A5254. Epub 2017 Jun 22.

49.

Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1 -weighted brain MRI acquisitions.

Papinutto N, Bakshi R, Bischof A, Calabresi PA, Caverzasi E, Constable RT, Datta E, Kirkish G, Nair G, Oh J, Pelletier D, Pham DL, Reich DS, Rooney W, Roy S, Schwartz D, Shinohara RT, Sicotte NL, Stern WA, Tagge I, Tauhid S, Tummala S, Henry RG; North American Imaging in Multiple Sclerosis Cooperative(NAIMS).

Magn Reson Med. 2018 Mar;79(3):1595-1601. doi: 10.1002/mrm.26776. Epub 2017 Jun 15.

50.

Longitudinal multiple sclerosis lesion segmentation data resource.

Carass A, Roy S, Jog A, Cuzzocreo JL, Magrath E, Gherman A, Button J, Nguyen J, Bazin PL, Calabresi PA, Crainiceanu CM, Ellingsen LM, Reich DS, Prince JL, Pham DL.

Data Brief. 2017 Apr 8;12:346-350. doi: 10.1016/j.dib.2017.04.004. eCollection 2017 Jun.

Supplemental Content

Loading ...
Support Center